These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21106750)

  • 1. Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire.
    Steers NJ; Currier JR; Kijak GH; di Targiani RC; Saxena A; Marovich MA; Kim JH; Michael NL; Alving CR; Rao M
    J Virol; 2011 Feb; 85(4):1541-53. PubMed ID: 21106750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein.
    Bozzacco L; Yu H; Dengjel J; Trumpfheller C; Zebroski HA; Zhang N; Küttner V; Ueberheide BM; Deng H; Chait BT; Steinman RM; Mojsov S; Fenyö D
    PLoS One; 2012; 7(7):e41897. PubMed ID: 22860026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II.
    SenGupta D; Norris PJ; Suscovich TJ; Hassan-Zahraee M; Moffett HF; Trocha A; Draenert R; Goulder PJ; Binder RJ; Levey DL; Walker BD; Srivastava PK; Brander C
    J Immunol; 2004 Aug; 173(3):1987-93. PubMed ID: 15265933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 variation diminishes CD4 T lymphocyte recognition.
    Harcourt GC; Garrard S; Davenport MP; Edwards A; Phillips RE
    J Exp Med; 1998 Nov; 188(10):1785-93. PubMed ID: 9815256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodominance of HLA-B27-restricted HIV KK10-specific CD8(+) T-cells is not related to naïve precursor frequency.
    Iglesias MC; Briceno O; Gostick E; Moris A; Meaudre C; Price DA; Ungeheuer MN; Saez-Cirion A; Mallone R; Appay V
    Immunol Lett; 2013 Jan; 149(1-2):119-22. PubMed ID: 23068784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.
    Dorrell L; Willcox BE; Jones EY; Gillespie G; Njai H; Sabally S; Jaye A; DeGleria K; Rostron T; Lepin E; McMichael A; Whittle H; Rowland-Jones S
    Eur J Immunol; 2001 Jun; 31(6):1747-56. PubMed ID: 11385619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvant.
    Korsholm KS; Karlsson I; Tang ST; Brandt L; Agger EM; Aagaard C; Andersen P; Fomsgaard A
    PLoS One; 2013; 8(5):e63575. PubMed ID: 23691069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo induction of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes and delayed-type hypersensitivity by a 23-amino acid peptide from the highly conserved region in major core protein p24.
    Nishino Y; Kameoka M; Okada Y; Zhong Q; Kimura T; Azuma I; Ikuta K
    Vaccine; 1994 May; 12(6):485-91. PubMed ID: 7913566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells.
    Norris PJ; Moffett HF; Brander C; Allen TM; O'Sullivan KM; Cosimi LA; Kaufmann DE; Walker BD; Rosenberg ES
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):315-25. PubMed ID: 15117455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Th1 immune response against HIV-1 Gag p24-derived peptides in mice expressing HLA-A02.01 and HLA-DR1.
    Pajot A; Schnuriger A; Moris A; Rodallec A; Ojcius DM; Autran B; Lemonnier FA; Lone YC
    Eur J Immunol; 2007 Sep; 37(9):2635-44. PubMed ID: 17668896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.
    Ladell K; Hashimoto M; Iglesias MC; Wilmann PG; McLaren JE; Gras S; Chikata T; Kuse N; Fastenackels S; Gostick E; Bridgeman JS; Venturi V; Arkoub ZA; Agut H; van Bockel DJ; Almeida JR; Douek DC; Meyer L; Venet A; Takiguchi M; Rossjohn J; Price DA; Appay V
    Immunity; 2013 Mar; 38(3):425-36. PubMed ID: 23521884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing the epitope flanking regions for optimal generation of CTL epitopes.
    Steers NJ; Currier JR; Jobe O; Tovanabutra S; Ratto-Kim S; Marovich MA; Kim JH; Michael NL; Alving CR; Rao M
    Vaccine; 2014 Jun; 32(28):3509-16. PubMed ID: 24795226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants.
    Klenerman P; Rowland-Jones S; McAdam S; Edwards J; Daenke S; Lalloo D; Köppe B; Rosenberg W; Boyd D; Edwards A
    Nature; 1994 Jun; 369(6479):403-7. PubMed ID: 7515165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming.
    Schlecht G; Loucka J; Najar H; Sebo P; Leclerc C
    J Immunol; 2004 Nov; 173(10):6089-97. PubMed ID: 15528345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition of two new epitopes on human immunodeficiency virus type 1 gag protein recognized by human CD8+ cytotoxic T lymphocyte clones.
    Kurane I; West K; Tuazon CU; Zeng W; Ennis FA
    J Clin Virol; 2003 May; 27(1):38-43. PubMed ID: 12727527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new variant cytotoxic T lymphocyte escape mutation in HLA-B27-positive individuals infected with HIV type 1.
    Ammaranond P; Zaunders J; Satchell C; van Bockel D; Cooper DA; Kelleher AD
    AIDS Res Hum Retroviruses; 2005 May; 21(5):395-7. PubMed ID: 15929701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 envelope resistance to proteasomal cleavage: implications for vaccine induced immune responses.
    Steers NJ; Ratto-Kim S; de Souza MS; Currier JR; Kim JH; Michael NL; Alving CR; Rao M
    PLoS One; 2012; 7(8):e42579. PubMed ID: 22880042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.
    Lucchiari-Hartz M; van Endert PM; Lauvau G; Maier R; Meyerhans A; Mann D; Eichmann K; Niedermann G
    J Exp Med; 2000 Jan; 191(2):239-52. PubMed ID: 10637269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse repertoire of HIV-1 p24-specific, IFN-gamma-producing CD4+ T cell clones following immune reconstitution on highly active antiretroviral therapy.
    Boritz E; Palmer BE; Livingston B; Sette A; Wilson CC
    J Immunol; 2003 Jan; 170(2):1106-16. PubMed ID: 12517980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.
    Kelleher AD; Long C; Holmes EC; Allen RL; Wilson J; Conlon C; Workman C; Shaunak S; Olson K; Goulder P; Brander C; Ogg G; Sullivan JS; Dyer W; Jones I; McMichael AJ; Rowland-Jones S; Phillips RE
    J Exp Med; 2001 Feb; 193(3):375-86. PubMed ID: 11157057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.